SRZN

Companies
NASDAQ
Surrozen, Inc.
Health Care
Price Chart
Overview

About SRZN

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Market Cap
$35.5M
Volume
167.2K
Avg. Volume
122.8K
P/E Ratio
-1.6741574
Dividend Yield
0.00%
Employees
69.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.49
Low Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for SRZN.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, SRZN shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$35.5M
Volume167.2K
P/E Ratio-1.67
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2024
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how SRZN fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025